British scientists warn a possible detriment of science and opinion of counsel, who said that using embryonic stem cells is against the ethics and public policy
The father of the sheep Dolly, Ian Wilmut, and other leading British scientists have expressed alarm at the general counsel's opinion of the Court of Justice against allowing the patenting of inventions based on embryonic stem cells human.
The man who cloned the first sheep and his colleagues argue that the French judge's legal opinion Yves Bot, the general counsel of the Luxembourg-based court, if accepted by the thirteen judges of the House, would mark the end of European research methods that could be used to cure degenerative diseases such as Parkinson's, among others.
In his opinion, he answered to the appeal by the owner of a German patent, the Advocate General pointed out that patents should be prohibited "an invention that uses embryonic stem cells " for its "industrial application" would using human embryos "as trivial matter, which would go against ethics and public policy. "
" Inventions relating to pluripotent stem cells can only be patented if not obtained at the expense of an embryo, whether for destruction or alteration "Bot said the judge in his legal opinion, which is not yet binding on the Court.
In strong reaction, reported today that the British newspaper The Independent, Ian Wilmut and twelve other leading researchers in the field of embryonic stem cells indicate that this legal opinion, if finally accepted, would in order to European research on embryonic cells.
"The general counsel's opinion is a threat to our research and European science in general. Patents are a key vehicle for providing new products for medical purposes," said Professor Austin Smith, president of the center Embryonic cell research Wellcome Trust at the University of Cambridge.
Professor Peter Coffey, a stem cell researcher at University College London, who expects to begin clinical trials to treat a type of blindness known as macular degeneration related to age, said banning such patents would allow U.S. and other European countries to exploit inventions in this sector.
According Coffey, the UK government has invested millions of pounds to create links between UK universities and pharmaceutical companies interested in developing therapies based on stem cells embryonic, all of which could endanger now the consequent negative impact on the economy of this country.
Source: eluniversal.com.mx
0 comments:
Post a Comment